Belladonna and Opium Suppositories CII
Generic Name and Formulations:
Belladonna extract (powdered), opium (powdered); 16.2mg/30mg, 16.2mg/60mg.
Indications for Belladonna and Opium Suppositories:
Moderate to severe pain associated with ureteral spasms.
1 supp rectally once or twice daily; max 4 doses/day.
Glaucoma. Severe hepatic or renal disease. Asthma. Narcotic idiosyncrasies. Respiratory depression. Convulsive disorders. Acute alcoholism. Delirium tremens. Premature labor.
Idiosyncrasies to atropine and related drugs. Cardiac disease. Incipient glaucoma. GI or GU obstruction. Increased intracranial pressure. Toxic psychosis. Myxedema. Drug abusers. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers.
Antispasmodic + opioid.
CNS effects potentiated with alcohol, other CNS depressants, MAOIs, tricyclic antidepressants, anticholinergics. Potentiated by anticholinergics.
Drowsiness, anticholinergic effects (eg, dry mouth, urinary retention, dizziness, blurred vision, constipation), photophobia, tachycardia, GI upset, pruritus, urticaria.
Formerly known under the brand name B&O Supprettes 15A, B&O Supprettes 16A.
Endocrinology Advisor Articles
- Relationship Between HbA1c and Coronary Artery Disease
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Bone Mineral Density Loss Eventually Stabilizes in Men With Type 1 Diabetes
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- FDA to Review Gimoti for Diabetic Gastroparesis in Adult Women
- FDA Approves First Mobile App for Use in Preventing Pregnancy
- Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation
- Treating Painful Diabetic Peripheral Neuropathy With Electroacupuncture